BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12426225)

  • 1. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.
    Talmud PJ; Hawe E; Miller GJ; Humphries SE
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1918-23. PubMed ID: 12426225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I; Aastveit AH; Jungner I; Walldius G
    J Intern Med; 2008 Jul; 264(1):30-8. PubMed ID: 18298486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL).
    Holme I; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Ann Med; 2008; 40(6):456-64. PubMed ID: 19160529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Patsch W; Sorlie PD; Heiss G; Bond MG; Davis CE
    Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
    Walldius G; Aastveit AH; Jungner I
    J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).
    Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
    Ling Y; Jiang J; Wu B; Gao X
    J Clin Lipidol; 2017; 11(3):646-656. PubMed ID: 28506386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
    BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.